Cargando…
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced hyperinflammation together with alteration of plasma proteins, erythrocyte deformability, and platelet activation, may affect blood viscosity. Thus...
Autores principales: | Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Al-Hamash, Sadiq M., Cavalu, Simona, El-Bouseary, Maisra M., Sonbol, Fatma I., Batiha, Gaber El-Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247235/ https://www.ncbi.nlm.nih.gov/pubmed/35783600 http://dx.doi.org/10.3389/fmed.2022.876017 |
Ejemplares similares
-
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail
por: Alkhayyat, Shadi Salem, et al.
Publicado: (2022) -
Hippo-YAP signaling and SARS-CoV-2 infection: a new mechanistic pathway
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2023)